Kyverna Therapeutics (KYTX) Institutional Ownership $2.78 -0.06 (-2.11%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$2.80 +0.02 (+0.68%) As of 02/21/2025 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Kyverna Therapeutics (NASDAQ:KYTX)CurrentInstitutional OwnershipPercentage18.08%Number ofInstitutional Buyers(last 12 months)60TotalInstitutional Inflows(last 12 months)$229.45MNumber ofInstitutional Sellers(last 12 months)11TotalInstitutional Outflows(last 12 months)$8.07M Get KYTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Kyverna Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data KYTX Institutional Buying and Selling by Quarter Kyverna Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/19/2025 Public Employees Retirement System of Ohio33,434$125K0.0%N/A0.077% 2/17/2025 Squarepoint Ops LLC11,488$43K0.0%N/A0.027% 2/17/2025 Two Sigma Advisers LP80,290$300K0.0%+375.1%0.186% 2/17/2025 Two Sigma Investments LP181,654$679K0.0%+47.9%0.421% 2/17/2025 Sphera Funds Management LTD.118,758$444K0.1%-52.2%0.275% 2/17/2025 Millennium Management LLC746,521$2.79M0.0%-40.4%1.729% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.14,288$53K0.0%+53.7%0.033% 2/17/2025 Integral Health Asset Management LLC350,000$1.31M0.1%+75.0%0.811% 2/17/2025 Jacobs Levy Equity Management Inc.461,959$1.73M0.0%+2,225.0%1.070% 2/17/2025 Corton Capital Inc.12,099$45K0.0%N/A0.028% Get the Latest News and Ratings for KYTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kyverna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Cubist Systematic Strategies LLC52,361$196K0.0%-24.1%0.121% 2/17/2025 Bridgeway Capital Management LLC80,000$299K0.0%N/A0.185% 2/17/2025 Bank of America Corp DE21,788$81K0.0%+41.6%0.050% 2/17/2025 BNP Paribas Financial Markets44,983$168K0.0%+65.4%0.104% 2/17/2025 Ameriprise Financial Inc.190,383$712K0.0%+55.1%0.441% 2/14/2025 Northern Trust Corp195,694$732K0.0%+46.1%0.453% 2/14/2025 Price T Rowe Associates Inc. MD593,688$2.22M0.0%-5.5%1.375% 2/14/2025 Stifel Financial Corp39,342$147K0.0%N/A0.091% 2/14/2025 Gilead Sciences Inc.4,126,119$15.43M1.0%N/A9.558% 2/13/2025 Marshall Wace LLP15,241$57K0.0%-52.7%0.035% 2/13/2025 XTX Topco Ltd43,949$164K0.0%-16.8%0.102% 2/13/2025 Barclays PLC89,586$336K0.0%+27.7%0.208% 2/13/2025 Renaissance Technologies LLC44,700$167K0.0%N/A0.104% 2/13/2025 Wells Fargo & Company MN179,012$670K0.0%+16.4%0.415% 2/12/2025 Geode Capital Management LLC539,682$2.02M0.0%+21.7%1.250% 2/12/2025 Franklin Resources Inc.692,028$2.59M0.0%-26.1%1.603% 2/12/2025 Wellington Management Group LLP274,414$1.03M0.0%+16.7%0.636% 2/12/2025 Norges Bank40,000$150K0.0%N/A0.093% 2/12/2025 JPMorgan Chase & Co.2,166,437$8.10M0.0%-9.3%5.018% 2/11/2025 Corebridge Financial Inc.12,811$48K0.0%+42.3%0.030% 2/6/2025 Charles Schwab Investment Management Inc.169,780$635K0.0%+1.9%0.393% 2/4/2025 Bank of New York Mellon Corp39,933$149K0.0%-7.7%0.093% 1/30/2025 Rhumbline Advisers25,920$97K0.0%+31.1%0.060% 1/24/2025 China Universal Asset Management Co. Ltd.9,154$34K0.0%N/A0.021% 1/15/2025 Kera Capital Partners Inc.376,131$1.41M0.4%N/A0.871% 12/26/2024 JPMorgan Chase & Co.2,387,352$11.67M0.0%+15.8%5.530% 11/27/2024 Franklin Resources Inc.936,961$4.58M0.0%+13.8%2.170% 11/19/2024 Barclays PLC70,167$343K0.0%+21.5%0.163% 11/16/2024 Geode Capital Management LLC443,312$2.17M0.0%+19.0%1.027% 11/15/2024 Barclays PLC70,167$343K0.0%+21.5%0.163% Watch This Robotics Demo Before March 17th (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo…11/15/2024 XTX Topco Ltd52,792$258K0.0%-36.6%0.122% 11/15/2024 Jane Street Group LLC39,193$192K0.0%+78.3%0.091% 11/15/2024 Wellington Management Group LLP235,123$1.15M0.0%-67.0%0.545% 11/15/2024 Sphera Funds Management LTD.248,651$1.22M0.2%+5.3%0.576% 11/15/2024 State Street Corp326,192$1.60M0.0%+3.2%0.756% 11/15/2024 Point72 Asset Management L.P.34,482$169K0.0%N/A0.080% 11/15/2024 Jacobs Levy Equity Management Inc.19,869$97K0.0%N/A0.046% 11/14/2024 Verition Fund Management LLC44,626$218K0.0%N/A0.103% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC101,900$498K0.0%-11.7%0.236% 11/13/2024 BNP Paribas Financial Markets27,197$133K0.0%+2,166.4%0.063% 11/13/2024 FMR LLC6,692$33K0.0%N/A0.016% 11/12/2024 Charles Schwab Investment Management Inc.166,635$815K0.0%+33.2%0.386% 10/24/2024 Novo Holdings A S1,850,000$9.05M0.4%+5.7%4.291% 10/11/2024 Creative Planning11,028$54K0.0%N/A0.026% 8/26/2024 Teachers Retirement System of The State of Kentucky21,410$161K0.0%+69.7%0.050% 8/20/2024 Novo Holdings A S1,750,000$13.13M0.7%+150.0%4.059% 8/15/2024 The Manufacturers Life Insurance Company37,794$283K0.0%+32.6%0.088% 8/15/2024 Millennium Management LLC923,082$6.92M0.0%+32.8%2.141% 8/15/2024 MBB Public Markets I LLC410,191$3.08M0.1%N/A0.951% 8/15/2024 Deerfield Management Company L.P. Series C1,983,000$14.87M0.2%+35.6%4.599% 8/15/2024 Affinity Asset Advisors LLC200,000$1.50M0.2%N/A0.464% 8/14/2024 Great Point Partners LLC499,152$3.74M0.7%+232.8%1.158% 8/14/2024 Marshall Wace LLP10,400$78K0.0%-93.3%0.024% 8/13/2024 Skandinaviska Enskilda Banken AB publ26,195$196K0.0%+55.8%0.061% 8/12/2024 XTX Topco Ltd83,286$625K0.1%N/A0.193% 8/12/2024 E Fund Management Co. Ltd.189,432$1.42M0.1%N/A0.439% 8/10/2024 Sofinnova Investments Inc.47,850$359K0.0%+378.5%0.111% 8/8/2024 Federated Hermes Inc.16,000$120K0.0%N/A0.037% 8/3/2024 TD Asset Management Inc90,242$677K0.0%N/A0.209% 8/1/2024 Rhumbline Advisers20,007$150K0.0%N/A0.046% 7/26/2024 Bank of New York Mellon Corp55,790$418K0.0%N/A0.129% 6/4/2024 DekaBank Deutsche Girozentrale7,500$181K0.0%N/A0.017% 5/28/2024 Teachers Retirement System of The State of Kentucky12,614$313K0.0%N/A0.029% 5/17/2024 Artal Group S.A.200,000$4.97M0.1%N/A0.464% 5/16/2024 Janus Henderson Group PLC606,500$15.04M0.0%N/A1.407% 5/16/2024 Bain Capital Life Sciences Investors LLC3,163,868$78.59M6.3%N/A7.338% 5/16/2024 Blackstone Inc.100,000$2.48M0.0%N/A0.232% 5/15/2024 Price T Rowe Associates Inc. MD929,634$23.09M0.0%N/A2.156% 5/15/2024 Avoro Capital Advisors LLC475,000$11.80M0.1%N/A1.102% 5/14/2024 StemPoint Capital LP41,000$1.02M0.3%N/A0.095% 5/10/2024 Vanguard Group Inc.264,215$6.56M0.0%N/A0.613% 5/2/2024 Jennison Associates LLC1,398,659$34.74M0.0%N/A3.244% (Data available from 1/1/2016 forward) KYTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of KYTX shares? During the previous two years, 63 institutional investors and hedge funds held shares of Kyverna Therapeutics. The most heavily invested institutionals were Bain Capital Life Sciences Investors LLC ($78.59M), Jennison Associates LLC ($34.74M), Gilead Sciences Inc. ($15.43M), Janus Henderson Group PLC ($15.04M), Deerfield Management Company L.P. Series C ($14.87M), Avoro Capital Advisors LLC ($11.80M), and Novo Holdings A S ($9.05M).Learn more on KYTX's institutional investors. What percentage of Kyverna Therapeutics stock is owned by institutional investors? 18.08% of Kyverna Therapeutics stock is owned by institutional investors. Learn more on KYTX's institutional investor holdings. Which institutional investors have been buying Kyverna Therapeutics stock? Of the 60 institutional investors that purchased Kyverna Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Gilead Sciences Inc. ($4.13M), Bain Capital Life Sciences Investors LLC ($3.16M), Jennison Associates LLC ($1.40M), Novo Holdings A S ($1.15M), Price T Rowe Associates Inc. MD ($929.63K), Janus Henderson Group PLC ($606.50K), and Deerfield Management Company L.P. Series C ($520.66K). How much institutional buying is happening at Kyverna Therapeutics? Institutional investors have bought a total of 17,175,671 shares in the last 24 months. This purchase volume represents approximately $229.45M in transactions. Which Kyverna Therapeutics major shareholders have been selling company stock? Of the 11 institutional investors that sold Kyverna Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($507.04K), Wellington Management Group LLP ($478.28K), Franklin Resources Inc. ($244.93K), JPMorgan Chase & Co. ($220.92K), Marshall Wace LLP ($162.34K), Sphera Funds Management LTD. ($129.89K), and XTX Topco Ltd ($39.34K). How much institutional selling is happening at Kyverna Therapeutics? Institutional investors have sold a total of 1,850,656 shares in the last 24 months. This volume of shares sold represents approximately $8.07M in transactions. Related Companies MLYS Major Shareholders TRDA Major Shareholders RNAC Major Shareholders HUMA Major Shareholders ARCT Major Shareholders SNDL Major Shareholders KALV Major Shareholders PROK Major Shareholders ABVX Major Shareholders ORGO Major Shareholders This page (NASDAQ:KYTX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kyverna Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kyverna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
